Literature DB >> 3932354

Preparation and characterization of recombinant DNA-derived human interferon-gamma.

T Arakawa, N K Alton, Y R Hsu.   

Abstract

An attempt was made to prepare a highly purified, active recombinant DNA-derived human interferon-gamma. When the protein was denatured in urea and refolded, gel filtration and sedimentation velocity experiments indicated the presence of two forms, which are different in size and are not in a rapid reversible equilibrium. The two forms could be chromatographically separated. Far-UV circular dichroic spectra indicated the presence of secondary structures for both forms. Near-UV circular dichroic spectra revealed that the smaller form is folded into a rigid tertiary structure. The antiviral activity of the two forms of interferon-gamma showed a significant difference, i.e. the smaller form was 4-8-fold more active than the larger form. A variety of experiments show that the smaller form is more active, homogeneous, soluble, and stable than the larger form.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932354

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Production and characterization of human gamma interferon from Escherichia coli.

Authors:  L Perez; J Vega; C Chuay; A Menendez; R Ubieta; M Montero; G Padron; A Silva; C Santizo; V Besada
Journal:  Appl Microbiol Biotechnol       Date:  1990-07       Impact factor: 4.813

Review 2.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

3.  The effect of benzyl alcohol on recombinant human interferon-gamma.

Authors:  X M Lam; T W Patapoff; T H Nguyen
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

4.  PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.

Authors:  Christine M Fam; Stephen P Eisenberg; Sharon J Carlson; Elizabeth A Chlipala; George N Cox; Mary S Rosendahl
Journal:  J Interferon Cytokine Res       Date:  2014-05-19       Impact factor: 2.607

Review 5.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

6.  Recombinant IFN-γ from the bank vole Myodes glareolus: a novel tool for research on rodent reservoirs of zoonotic pathogens.

Authors:  Francesca Torelli; Steffen Zander; Heinz Ellerbrok; Georg Kochs; Rainer G Ulrich; Christian Klotz; Frank Seeber
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

7.  Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.

Authors:  Y Tsutsumi; T Kihira; S Tsunoda; T Kanamori; S Nakagawa; T Mayumi
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.